Atypical depression
Abstract
The authors conducted Pubmed searches to examine the epidemiological characteristics, symptoms, association with bipolar disorder, personality and temperament features, biology, and pharmacotherapy response of atypical depression and significance of current knowledge about this subtype of depression in treatment planning. Atypical depression has a high prevalence rate, starts early in life, tends to last longer, is more likely to occur in people with bipolar disorder, has high comorbidity of anxiety disorders, carries more risk of suicidal behavior, and has distinct personality psychopathology and biological traits. Atypical depression is an important specifier with significance in terms of predicting clinical course of depression, and hence in treatment planning and service use.
Keywords: Atypical depression; epidemiology; pharmacotherapy.
References
- 
    - Rosenbaum JF. Depression and its subtypes: A treatment update. J Clinical Psychiatry. 1998;59(suppl 18):37–8. - PubMed
 
- 
    - Quitkin FM, McGarth PJ, Stewart JW, Klein DF. A reappraisal of atypical depression. Am J Psychiatry. 2003;160:798–800. - PubMed
 
- 
    - McGrath PJ, Stewart JW, Janal MN, et al. A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. Am J Psychiatry. 2000;157:344–50. - PubMed
 
- 
    - Rabkin JG, Quitkin FM, McGrath PJ, et al. American Psychiatric Association. DSM IV Source Book. Vol. 2. Washington, DC: American Psychiatric Press Inc.; 1996. Should atypical depression be included in DSM IV? pp. 239–60.
 
- 
    - McGrath PJ, Stewart JW, Harrison WM, et al. Predictive value of symptoms of atypical depression for differential drug treatment outcome. J Clin Psychopharmacol. 1992;12:197–202. - PubMed
 
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
